Login to Your Account


Akebia blossoms: IPO upsized, raises $100M for CKD anemia effort

By Randy Osborne
Staff Writer

Friday, March 21, 2014

Akebia Therapeutics Inc. beat the target amount raised in its initial public offering to raise about $100 million, and started off trading with a bang, closing Thursday (NASDAQ:AKBA) at $26.70, up 57 percent.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription